Consolidated Statements of Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Retained Earnings (Deficit)	Accumulated Other Comprehensive Loss
Balance, shares at Mar. 31, 2022		31,268
Beginning balance at Mar. 31, 2022	$ 164,049	$ 6,483	$ 158,093	$ (527)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(105,399)		(105,399)
Foreign currency translation adjustment, including income tax expense (benefit)	(951)			(951)
Stock-based compensation expense	3,885	$ 3,885
Common stock issued under equity compensation plan, net of shares withheld for tax payments (in shares)		458
Common stock issued under equity compensation plan, net of shares withheld for tax payments	(497)	$ (497)
Common stock issued under employee stock purchase plan (in shares)		119
Common stock issued under employee stock purchase plan	213	$ 213
Balance, shares at Mar. 31, 2023		31,845
Ending balance at Mar. 31, 2023	61,300	$ 10,084	52,694	(1,478)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(90,370)		(90,370)
Foreign currency translation adjustment, including income tax expense (benefit)	(43)			(43)
Issuance of common stock upon sale of shares and exercise of pre-funded warrants (in shares)		4,098
Issuance of common stock upon sale of shares and exercise of pre-funded warrants	1,671	$ 1,671
Stock-based compensation expense	3,688	$ 3,688
Common stock issued under equity compensation plan, net of shares withheld for tax payments (in shares)		393
Common stock issued under equity compensation plan, net of shares withheld for tax payments	(123)	$ (123)
Common stock issued under employee stock purchase plan (in shares)		76
Common stock issued under employee stock purchase plan	64	$ 64
Balance, shares at Mar. 31, 2024		36,412
Ending balance at Mar. 31, 2024	$ (23,813)	$ 15,384	$ (37,676)	$ (1,521)